Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Notice of NCATS Withdrawal from Participation in PAR-18-689, Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) ✔ NOT-TR-20-024 04/21/2020 Notice of Change to Funding Opportunity
Notice of Change in Expiration Date and Cancellation of Final Three Receipt Dates for RFA-NS-19-017 "HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)." ✘ NOT-NS-20-048 04/14/2020 Notice of Change to Funding Opportunity
Notice of Change in Expiration Date and Cancellation of Final Three Receipt Dates for RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)." ✘ NOT-NS-20-047 04/14/2020 Notice of Change to Funding Opportunity
Notice of Change in Expiration Date and Cancellation of Final Three Receipt Dates for RFA-NS-19-018 "HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)." ✘ NOT-NS-20-049 04/14/2020 Notice of Change to Funding Opportunity
Notice of Change in Expiration Date of RFA-EB-18-003 "HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)" ✘ NOT-EB-20-009 04/13/2020 Notice of Change to Funding Opportunity
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) ✔ PAR-23-267 U43/U44 04/18/2023 10/06/2025 NA
RESCINDED - Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects that Involve Human Subjects Research ✔ NOT-TR-20-019 04/09/2020 Notice of Information
Notice of NCATS' Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)" ✔ NOT-TR-20-013 04/08/2020 Notice of Change to Funding Opportunity
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed ✔ PAR-23-268 UT1 04/18/2023 10/06/2025 NA
Notice of NCATS Withdrawal from Participation in PAR-18-691, "Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional) ✔ NOT-TR-20-020 04/08/2020 Notice of Change to Funding Opportunity
Showing Row 231 to 240 of 282

Last updated on February 19, 2025